Surgical treatment of patients with chest wall metastases

Bukharov A.V.; Derzhavin V.A.; Yadrina A.V.; Erin D.A.; Elkhov D.O.; Aliev M.D.

doi:https://doi.org/10.17116/hirurgia202208125

Bukharov A.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-2976-8895

Derzhavin V.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-4385-9048

Yadrina A.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-7944-3108

Erin D.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-3501-036X

Elkhov D.O.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

ORCID: 0000-0001-5772-4067

Aliev M.D.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

ORCID: 0000-0003-2706-4138

Surgical treatment of patients with chest wall metastases

Authors:

Bukharov A.V., Derzhavin V.A., Yadrina A.V., Erin D.A., Elkhov D.O., Aliev M.D.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2022;(8): 25‑30

DOI: 10.17116/hirurgia202208125

Read: 1870 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Bukharov AV, Derzhavin VA, Yadrina AV, Erin DA, Elkhov DO, Aliev MD. Surgical treatment of patients with chest wall metastases. Pirogov Russian Journal of Surgery. 2022;(8):25‑30. (In Russ.)
https://doi.org/10.17116/hirurgia202208125

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate postoperative outcomes in patients with chest wall metastases.

MATERIAL AND METHODS

We analyzed 40 patients who underwent surgery for chest wall metastatic lesions. Fourteen (35%) patients had sternal lesion, 26 (65%) ones — rib metastases. We used implants for chest wall defect closure in 15 (37.5%) patients. Chest wall repair with autologous tissues was performed in 19 (47.5%) patients.

RESULTS

Median survival was 17 months. Most patients (n=30, 75%) showed improvement in the quality of life according to Karnofsky and EGOG scale after surgery. Continued tumor growth occurred in 4 (10%) patients within 8—16 months after surgery. There were 2 patients who suffered from tumor recurrence accompanied by other metastatic foci (progression). Complications were diagnosed in 5 (12.5%) patients. Tactical errors were identified in 4 (10%) patients and they were associated with progression of cancer in the form of new metastatic foci within 6 months after surgery.

CONCLUSION

Active surgical approach for bone metastases in patients with favorable cancer-related prognosis can improve quality of life and survival at least in case of solitary lesions. New program for treatment strategy selection based on prognosis of life expectancy and algorithms of surgical treatment will reduce the risk of erroneous management and increase its effectiveness.

Keywords:

surgical treatment

chest wall metastases

oncological prognosis

Authors:

Bukharov A.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-2976-8895

Derzhavin V.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-4385-9048

Yadrina A.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-7944-3108

Erin D.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

ORCID: 0000-0002-3501-036X

Elkhov D.O.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

ORCID: 0000-0001-5772-4067

Aliev M.D.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

ORCID: 0000-0003-2706-4138

Received:

03.09.2021

Accepted:

25.01.2022

Close metadata

References:

Aliev MD. Onco-orthopedics yesterday, today, tomorrow. Vestnik onkologicheskogo obshchestva. 2013;5(598):3-4. (In Russ.).
Bukharov AV, Aliev MD, Derzhavin VA, Yadrina AV. Strategy for personalized surgical treatment of cancer patients with bone metastases. Onkologiya. Journal im. P.A. Hertsena. 2020;9:3:61-65. (In Russ.).
Bukharov AV, Derzhavin VA, Erin DA, Yadrina AV, Aliev MD. Surgical treatment of metastatic lesions of the pelvic bones. Sovremennaya onkologiya. 2020;22:72-76. (In Russ.).
Vishnevskiy AA, Rudakov SS, Milanov NO. Khirurgiya grudnoy stenki: rukovodstvo. M.: Vidar; 2005. (In Russ.).
Kaprin AD, Starinskiy VV, Shakhzadova AO. The state of cancer care for the population of Russia in 2019. P. Hertsen Moscow Oncology Research Institute — branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation. 2020. (In Russ.).
Larin IA, Tarasov VA, Khubulava GG, Gavrilov YeK. Vozmozhnosti operativnogo lecheniya bol’nykh s obshirnymi zlokachestvennymi porazheniyami grudnoy stenki. Klinicheskaya meditsina. 2015;93(7):40-45. (In Russ.).
Bauer HC. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br. 2005;87:608-617.
Ehne J, Tsagozis P. Current concepts in the surgical treatment of skeletal metastases. World J Orthop. 2020;11(7):319-327.
Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PLoS ONE. 2011;6:e19956. 10.1371.
Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 2018;18(1):44.
Katagiri H, Okada R, Takagi T, et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014;3:1359-1367.
Kosmin M, Padhani AR, Gogbashian A, Woolf D, Ah-See ML, Ostler P, Sutherland S, Miles D, Noble J, Koh DM, Marshall A, Dunn J, Makris A. Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone. Radiology. 2020;297(3):622-629.
Liu D, Wu J, Lin C, Andriani L, Ding S, Shen K, Zhu L. Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study. Front Oncol. 2020;10:580112.
Lun DX, Xu LN, Wang F, Yang XG, Yu XC, Zhang GC, Hu YC. Prognostic Differences in Patients with Solitary and Multiple Spinal Metastases. Orthop Surg. 2019;11(3):443-450.
Mandal CC. Osteolytic metastasis in breast cancer: effective prevention strategies. Expert Rev Anticancer Ther. 2020;20(9):797-811.
Ratasvuori M, Wedin R, Keller J, Nottrott M, Zaikova O, Bergh P, et al. Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis. Surg Oncol. 2013;22:132-138. https://doi.org/10.1016/j.suronc.2013.02.008
Ryan C, Stoltzfus KC, Horn S, Chen H, Louie AV, Lehrer EJ, Trifiletti DM, Fox EJ, Abraham JA, Zaorsky NG. Epidemiology of bone metastases. Bone. 2020;115783.
Wang D, Bai Y, Huo Y, Ma C. FDG PET Predicts the Effects of (131)I and Prognosis for Patients with Bone Metastases from Differentiated Thyroid Carcinoma. Cancer Manag Res. 2020;12:13223-13232.
Wang F, Zhang H, Yang L, Yang XG, Zhang HR, Li JK, Qiao RQ, Hu YC. Epidemiological Characteristics of 1196 Patients with Spinal Metastases: A Retrospective Study. Orthop Surg. 2019;11(6):1048-1053.